Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-312843
Filing Date
2013-07-31
Accepted
2013-07-31 17:15:26
Documents
13
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d554827d10q.htm 10-Q 592628
2 EX-10.1 d554827dex101.htm EX-10.1 17826
3 EX-10.2 d554827dex102.htm EX-10.2 10243
4 EX-15 d554827dex15.htm EX-15 2584
5 EX-31.1 d554827dex311.htm EX-31.1 7388
6 EX-31.2 d554827dex312.htm EX-31.2 7681
7 EX-32 d554827dex32.htm EX-32 6626
  Complete submission text file 0001193125-13-312843.txt   3910240

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ctic-20130630.xml EX-101.INS 281052
9 XBRL TAXONOMY EXTENSION SCHEMA ctic-20130630.xsd EX-101.SCH 26941
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20130630_cal.xml EX-101.CAL 47177
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20130630_def.xml EX-101.DEF 160230
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20130630_lab.xml EX-101.LAB 235502
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20130630_pre.xml EX-101.PRE 186595
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 13999916
SIC: 2834 Pharmaceutical Preparations